[1] Xin ZHAO, Long TIAN, Ⅺ Qiang. Study on marker recognition using kV CBCT. China Medical Devices, 34, 41-44(2019).

[2] Jiecheng YAN, Long TIAN, Yimin HU. Comparing the calibration accuracy of two image guided methods in bladder cancer radiotherapy. Beijing Biomedical Engineering, 40, 303-308(2021).

[3] Y Lei, S Tian, Z Tian et al. Accurate CBCT prostate segmentation aided by CBCT-based synthetic MRI. Medical Physics, 46, E132-E132(2019).

[4] F Fontana, F Piacentino, A M Ierardi et al. Comparison between CBCT and fusion PET/CT-CBCT guidance for lung biopsies. CardioVascular and Interventional Radiology, 44, 73-79(2021).

[5] Long TIAN, Xuewu FAN, Rui XU et al. Comparison on T2WI and T2*WI for radiotherapy planning of prostate cancer. Chinese Journal of Interventional Imaging and Therapy, 19, 239-244(2022).

[6] X Yang, Y Fu, Y Lei et al. Unsupervised learning-based CBCT-CT deformable image registration for CBCT-guided abdominal radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 111, e535-e536(2021).

[7] Long TIAN, Qiang XI, Xin ZHAO et al. Comparison of cone beam computed tomography calibrations based on soft tissue grey value and implanted markers in image-guided radiotherapy for bladder cancer. Chinese Journal of Medical Physics, 35, 31-35(2018).

[8] K H Brown, M Ghita, G Schettino et al. Evaluation of a novel liquid fiducial marker, BioXmark®, for small animal image-guided radiotherapy applications. Cancers, 12, 1276(2020).

[9] R A Thomas, E Y Rasmas, A Morten. Formula of gel for guided radiotherapy. (. https://doc.taixueshu.com/patent/CN105407927B.html

[10] M de Ridder, L C Gerbrandy, de Reijke T M et al. BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial. British Journal of Radiology, 93, 20200241(2020).

[11] M Machiels, F E M Voncken, P Jin et al. A novel liquid fiducial marker in esophageal cancer image guided radiation therapy: technical feasibility and visibility on imaging. Practical Radiation Oncology, 9, e506-e515(2019).

[12] J S Rydhög, S R Mortensen, K R Larsen et al. Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancer. Radiotherapy and Oncology, 121, 64-69(2016).

[13] R De Roover, W Crijns, K Poels et al. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer. Medical Physics, 45, 2205-2217(2018).

[14] H Y Kim, Y H Choi, S J Lee. Effect of sedation anesthesia with intravenous propofol on transrectal ultrasound-guided prostate biopsy outcomes. Journal of Korean Medical Science, 37, e115(2022).

[15] S Helrich, W Pate, N Garg et al. Comparison of magnetic resonance imaging to ultrasound for prostate sizing. The Canadian Journal of Urology, 28, 10889-10899(2021).

[16] S Takeda, T Fujimoto, K Onda. Traumatic cervical vertebral artery dissection: a case with cerebral infarct due to newly formed thrombus in the cerebral arteries. Neuropathology, 40, 501-506(2020).

[17] C Y Xu, W G Sun, L Y Fang et al. The value of multimodal imaging in the diagnosis of primary cardiac angiosarcoma. Echocardiography, 38, 1474-1477(2021).